Molecular Analysis of L-Asparaginases for Clarification of the Mechanism of Action and Optimization of Pharmacological Functions

L-asparaginases (EC 3.5.1.1) are a family of enzymes that catalyze the hydrolysis of L-asparagine to L-aspartic acid and ammonia. These proteins with different biochemical, physico-chemical and pharmacological properties are found in many organisms, including bacteria, fungi, algae, plants and mammals. To date, asparaginases from E. coli and Dickeya dadantii (formerly known as Erwinia chrysanthemi) are widely used in hematology for the treatment of lymphoblastic leukemias. However, their medical use is limited by side effects associated with the ability of these enzymes to hydrolyze L-glutamine, as well as the development of immune reactions. To solve these issues, gene-editing methods to introduce amino-acid substitutions of the enzyme are implemented. In this review, we focused on molecular analysis of the mechanism of enzyme action and to optimize the antitumor activity. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Journal
Publisher
MDPI AG
Number of issue
3
Language
English
Status
Published
Number
599
Volume
14
Year
2022
Organizations
  • 1 Institute of Biomedical Chemistry, Pogodinskaya Str. 10/8, Moscow, 119121, Russian Federation
  • 2 Department of Biochemistry, Peoples’ Friendship, University of Russia (RUDN University), Miklukho-Maklaya Str. 6, Moscow, 117198, Russian Federation
  • 3 Laboratory of Combined Treatment, N.N. Blokhin Cancer Research Center, Kashirskoe Shosse 24, Moscow, 115478, Russian Federation
  • 4 Center of Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory Sirius, Olimpiisky Prospect 1, Sochi, 354340, Russian Federation
Keywords
Acute lymphoblastic leukemia; Immunogenicity; L-asparaginase; Protein engineering; Site-directed mutagenesis; Substrate specificity
Share

Other records